This is a demo store. No orders will be fulfilled.

Roflupram, a novel phosphodiesterase 4 inhibitor, inhibits lipopolysaccharide-induced neuroinflammatory responses through activation of the AMPK/Sirt1 pathway

INTERNATIONAL IMMUNOPHARMACOLOGY [2021]
Dan Li, Jiangping Xu, Yunyun Qin, Ningbo Cai, Yufang Cheng, Haitao Wang
MATERIALS

Shall we send you a message when we have discounts available?

Remind me later

Thank you! Please check your email inbox to confirm.

Oops! Notifications are disabled.